MAPT and Alzheimer disease: In primary tauopathies such as PSP, FTDP-17, CBD, Pick’s disease, and AGD, tau pathology is considered the primary cause of neurodegeneration, whereas in secondary tauopathies such as AD and CTE, tau pathology is considered as having diverse driving force [14].